Austar Lifesciences Yönetim
Yönetim kriter kontrolleri 3/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Mars Ho
İcra Kurulu Başkanı
CN¥935.0k
Toplam tazminat
| CEO maaş yüzdesi | 98.3% |
| CEO görev süresi | 10.8yrs |
| CEO sahipliği | 66.3% |
| Yönetim ortalama görev süresi | 10.4yrs |
| Yönetim Kurulu ortalama görev süresi | 10.4yrs |
Son yönetim güncellemeleri
Recent updates
Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 32% But Its Business Prospects Need A Lift Too
Oct 16
Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥19m |
| Mar 31 2024 | n/a | n/a | -CN¥26m |
| Dec 31 2023 | CN¥935k | CN¥919k | -CN¥33m |
| Jun 30 2023 | n/a | n/a | CN¥51m |
| Mar 31 2023 | n/a | n/a | CN¥78m |
| Dec 31 2022 | CN¥895k | CN¥880k | CN¥104m |
| Sep 30 2022 | n/a | n/a | CN¥96m |
| Jun 30 2022 | n/a | n/a | CN¥105m |
| Mar 31 2022 | n/a | n/a | CN¥191m |
| Dec 31 2021 | CN¥865k | CN¥850k | CN¥277m |
| Sep 30 2021 | n/a | n/a | CN¥258m |
| Jun 30 2021 | n/a | n/a | CN¥238m |
| Mar 31 2021 | n/a | n/a | CN¥136m |
| Dec 31 2020 | CN¥927k | CN¥911k | CN¥33m |
| Sep 30 2020 | n/a | n/a | CN¥25m |
| Jun 30 2020 | n/a | n/a | CN¥17m |
| Mar 31 2020 | n/a | n/a | CN¥12m |
| Dec 31 2019 | CN¥918k | CN¥902k | CN¥8m |
| Sep 30 2019 | n/a | n/a | CN¥8m |
| Jun 30 2019 | n/a | n/a | CN¥8m |
| Mar 31 2019 | n/a | n/a | CN¥4m |
| Dec 31 2018 | CN¥880k | CN¥865k | CN¥107k |
| Sep 30 2018 | n/a | n/a | -CN¥16m |
| Jun 30 2018 | n/a | n/a | -CN¥33m |
| Mar 31 2018 | n/a | n/a | -CN¥43m |
| Dec 31 2017 | CN¥1m | CN¥1m | -CN¥54m |
Tazminat ve Piyasa: Mars 'nin toplam tazminatı ($USD 129.16K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 233.13K ).
Tazminat ve Kazançlar: Mars şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Mars Ho (62 yo)
10.8yrs
Görev süresi
CN¥935,000
Tazminat
Mr. Kwok Keung Ho, also known as Mars, is the Founder of Austar Lifesciences Limited and serves as its Chairman of the Board and Chief Executive Officer. Mr. Ho is responsible for overseeing the business,...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | no data | CN¥935.00k | 66.27% HK$ 224.2m | |
| Executive Director | 10.4yrs | CN¥2.13m | Veri yok | |
| Executive Director | 10.4yrs | CN¥1.11m | Veri yok | |
| Executive Director | 10.4yrs | CN¥2.26m | 7.27% HK$ 24.6m | |
| Vice President of Corporate Development | 3.9yrs | Veri yok | Veri yok | |
| Company Secretary | 2.1yrs | Veri yok | Veri yok |
10.4yrs
Ortalama Görev Süresi
58yo
Ortalama Yaş
Deneyimli Yönetim: 6118 'un yönetim ekibi deneyimli ve deneyimlidir ( 10.4 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 10.8yrs | CN¥935.00k | 66.27% HK$ 224.2m | |
| Executive Director | 10.4yrs | CN¥2.13m | Veri yok | |
| Executive Director | 10.4yrs | CN¥1.11m | Veri yok | |
| Executive Director | 10.8yrs | CN¥2.26m | 7.27% HK$ 24.6m | |
| Independent Non-Executive Director | 10.1yrs | CN¥161.00k | Veri yok | |
| Independent Non-Executive Director | 7.1yrs | CN¥161.00k | Veri yok | |
| Independent Non-Executive Director | 10.1yrs | CN¥161.00k | Veri yok | |
| Non-Executive Director | 10.4yrs | CN¥632.00k | Veri yok |
10.4yrs
Ortalama Görev Süresi
51.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 6118 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 10.4 yıldır).